Bacteria: atypical and cell-wall-deficient

Mycoplasma pneumoniae

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

A small bacterium without a cell wall that spreads by respiratory droplets, often in households, schools and institutions.

Infections

Tracheobronchitis and atypical ("walking") pneumonia; occasionally rash, hemolysis or neurological complications.

Signs and symptoms

Gradual onset of cough, sore throat, low-grade fever, fatigue; the cough can persist.

Antibiotic and antimicrobial resistance

No cell wall, so beta-lactams are ineffective; macrolide resistance is increasing.

Treatment considerations

Macrolides (azithromycin), doxycycline or a respiratory fluoroquinolone.

No cell wall: not seen on Gram stain, schematic
No cell wall: not seen on Gram stain. Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Mycoplasma pneumoniae infection.
  2. ATS / IDSA. Community-Acquired Pneumonia in Adults guideline.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.